Cargando…
Discrepancies between FDA documents and ClinicalTrials.gov for Orphan Drug-related clinical trial data
Clinical trial registries such as ClinicalTrials.gov (CTG) hold large amounts of data regarding trials. Drugs for rare diseases are known as orphan drugs (ODs), and it is particularly important that trials for ODs are registered, and the data in the trial record are accurate. However, there may be d...
Autores principales: | Choudhury, Mohua Chakraborty, Chakraborty, Indraneel, Saberwal, Gayatri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021800/ https://www.ncbi.nlm.nih.gov/pubmed/36962222 http://dx.doi.org/10.1371/journal.pgph.0000261 |
Ejemplares similares
-
Rare disease patients in India are rarely involved in international orphan drug trials
por: Chakraborty, Monoswi, et al.
Publicado: (2022) -
Some data quality issues at ClinicalTrials.gov
por: Chaturvedi, Neha, et al.
Publicado: (2019) -
An Analysis of Sponsors/Collaborators of 69,160 Drug Trials Registered with ClinicalTrials.gov
por: Keezhupalat, Shruthi Muralidharan, et al.
Publicado: (2016) -
The work, goals, challenges, achievements, and recommendations of orphan medicinal product organizations in India: an interview-based study
por: Choudhury, Mohua Chakraborty, et al.
Publicado: (2019) -
Hidden duplicates: 10s or 100s of Indian trials, registered with ClinicalTrials.gov, have not been registered in India, as required by law
por: Kumari, Sangeeta, et al.
Publicado: (2020)